CD226 and melanoma: We investigated the effect of BRAF-i and MEK-i on the expression of activating NK receptors/co-receptors that have been shown to play a major role in NK-mediated melanoma cell lysis (i.e. NKp46, NKp30, NKG2D and DNAM-1) [34–36].